Abstract
Background
We aim to investigate the safety and efficacy of radiofrequency ablation in the treatment of solitary hepatocellular carcinoma (3–5 cm) in comparison with surgical resection.
Methods
Included in this study were 388 patients with primary and solitary hepatocellular carcinoma, of whom 196 patients underwent surgical resection and the other 192 patients received radiofrequency ablation. Clinicopathological characteristics, prognosis, post-treatment complications, hospital stay, and financial expenditures between the two groups were compared retrospectively.
Results
The result of propensity score matching and subgroup analysis showed that the 1-, 3-, and 5-year overall survival and disease-free survival were comparable in patients with tumors of 3–4 cm in diameter between surgical resection and radiofrequency ablation groups. However, when the tumor size exceeded 4 cm in diameter, surgical resection exhibited a superior long-term prognosis compared with radiofrequency ablation. Nevertheless, hepatectomy was associated with high occurrences of postoperative complications, long hospital stay, and high hospitalization cost as compared with radiofrequency ablation. Further analysis of the relationship between tumor size and pathological features of hepatocellular carcinoma showed that tumors larger than 4 cm were positively correlated with a high rate of microvascular invasion and satellite nodule formation.
Conclusion
For solitary hepatocellular carcinoma of 3–4 cm in diameter, radiofrequency ablation could achieve a comparable prognosis with a low incidence of post-treatment complications and low hospitalization costs, while surgical resection is recommended for solitary hepatocellular carcinoma tumors of 4–5 cm in diameter when long-term prognosis is considered.
Similar content being viewed by others
References
Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. CA-Cancer J Clin. 2015;65(2):87–108.
Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–14.
Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844–55.
Tanaka M, Katayama F, Kato H, et al. Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. J Epidemiol. 2011;21(6):401–16.
McGlynn KA, Petrick JL, London WT. Global Epidemiology of Hepatocellular Carcinoma An Emphasis on Demographic and Regional Variability. Clinics in liver disease. 2015;19(2):223–238.
Tian QJ, Jia JD. Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia. Hepatology International. 2016;10(6):854–60.
Bruix J, Reig M, Sherman M. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology. 2016;150(4):835–53.
de Lope CR, Tremosini S, Forner A,et al. Management of HCC. Journal of hepatology. 2012;56:S75-S87.
Lee SH, Jin YJ, Lee JW. Survival benefit of radiofrequency ablation for solitary (3-5cm) hepatocellular carcinoma: An analysis for nationwide cancer registry. Medicine. 2017;96(44):7.
Xu XL, Liu XD, Liang M, Luo BM. Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis. Radiology. 2018;287(2):461–72.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo Classification of Surgical Complications Five-Year Experience. Annals of Surgery. 2009;250(2):187–96.
Guo WX, Zhai B, Lai ECH, Li N, Shi J, Lau WY, et al. Percutaneous Radiofrequency Ablation versus Partial Hepatectomy for Multicentric Small Hepatocellular Carcinomas: A Nonrandomized Comparative Study. World Journal of Surgery. 2010;34(11):2671–6.
Kulik L, Heimbach JK, Zaiem F, et al. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis. Hepatology. 2018;67(1):381–400.
Lu H, Lu L, Zhang F,et al. Living donor liver transplantation: where do we stand and where are we going? Hepatobiliary Surgery and Nutrition. 2016;5(2):141–4.
Chen SL, Peng ZW, Lin MX, et al. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study. Eur Radiol. 2018;28(9):3651–60.
Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative Study. Radiology. 2012;262(3):1022–33.
Lupo L, Panzera P, Giannelli G, et al. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB : the official journal of the International Hepato Pancreato Biliary Association. 2007;9(6):429–34.
Banerjee S, Wang DS, Kim HJ, et al. A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma. Hepatology. 2015;62(3):792–800.
Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Annals of Surgical Oncology. 2008;15(5):1375–82.
Finn RS, Zhu AX, Farah W, et al. Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis. Hepatology. 2018;67(1):422–35.
Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of Microvascular Invasion Before Hepatectomy for Hepatocellular Carcinoma. Journal of Surgical Oncology. 2010;102(5):462–8.
Roayaie S, Blume IN, Thung SN, et al. A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma. Gastroenterology. 2009;137(3):850–5.
Cucchetti A, Piscaglia F, Grigioni AD, et al. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study. Journal of hepatology. 2010;52(6):880–8.
Hwang S, Lee YJ, Kim KH, et al. The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients. J Gastrointest Surg. 2015;19(7):1281–90.
McHugh PP, Gilbert J, Vera S,et al. Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. Hpb. 2010;12(1):56–61
Huang G, Lau WY, Zhou WP, et al. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels. Jama Surgery. 2014;149(6):519–27.
Acknowledgements
Thanks for Dr. Xu Lin’s help (an intervention radiologist) in the description of RFA.
Funding
This study was supported by the General Program of Shanghai Municipal Commission of Health and Family Planning (No. 201440445) and the National Nature Science Foundation of China (No. 81372355).
Author information
Authors and Affiliations
Contributions
Guang-shun Yang, Qing-wang Ye, and Shu-jie Pang designed the project. Qing-wang Ye and Shu-jie Pang wrote the manuscript with Guang-shun Yang. Guang-shun Yang and Lin Bin provided revisions of the manuscript; Yang Ning, Hai-bin Zhang, Fu Yong, and Guang-shunYang collected and assembled the data; Qing-wang Ye, Shu-jie Pang, Lin Bin, and Guang-shun Yang analyzed the data and interpreted results; and all authors have given their final approval for the manuscript.
Corresponding authors
Ethics declarations
Ethics Approval and Consent to Participate
This study complied with the ethical guidelines of the Declaration of Helsinki and was approved by our Ethics Committee of the hospital. Informed consent was obtained from all patients before treatment for their data to be used in this study.
Conflict of Interest
The authors declare that there are no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ye, Qw., Pang, Sj., Yang, N. et al. Safety and Efficacy of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma (3–5 cm): a Propensity Score Matching Cohort Study. J Gastrointest Surg 23, 1549–1558 (2019). https://doi.org/10.1007/s11605-019-04229-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-019-04229-6